Compare HAE & JOBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HAE | JOBY |
|---|---|---|
| Founded | 1971 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Aerospace |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.4B |
| IPO Year | 1996 | 2020 |
| Metric | HAE | JOBY |
|---|---|---|
| Price | $118.98 | $4.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 11 |
| Target Price | ★ $124.50 | $10.34 |
| AVG Volume (30 Days) | 620.2K | ★ 19.0M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $910,373,000.00 | $53,425,000.00 |
| Revenue This Year | $6.21 | $126.06 |
| Revenue Next Year | $5.54 | $77.68 |
| P/E Ratio | $168.90 | ★ N/A |
| Revenue Growth | N/A | ★ 39183.09 |
| 52 Week Low | $48.98 | $4.43 |
| 52 Week High | $123.77 | $17.51 |
| Indicator | HAE | JOBY |
|---|---|---|
| Relative Strength Index (RSI) | 68.45 | 23.82 |
| Support Level | $100.92 | N/A |
| Resistance Level | N/A | $6.57 |
| Average True Range (ATR) | 3.43 | 0.24 |
| MACD | 1.11 | -0.09 |
| Stochastic Oscillator | 79.00 | 15.93 |
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Joby Aviation Inc is a transportation company developing an all-electric, vertical take-off and landing (eVTOL) air taxi for commercial passenger service. Its Joby eVTOL aircraft is designed to transport a pilot and up to four passengers or an expected payload of up to 1,000 pounds at speeds of up to 200 mph. The aircraft is optimized for urban routes, with a target range of up to 100 miles on a single charge. The company is also developing an app-based platform that will help consumers to book rides directly through its service. It has one operating and reportable segment, air transportation and related services. The company's revenue consists of passenger revenue, which includes revenue generated from the transportation of passengers via helicopter or fixed wing aircraft.